Serologically Active, Clinically Stable Systemic Lupus Erythematosus

NCT00000421 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Prednisone
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]